Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BI-3706674 by Boehringer Ingelheim International for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
BI-3706674 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction....
BI-3706674 by Boehringer Ingelheim International for Esophageal Cancer: Likelihood of Approval
BI-3706674 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Esophageal Cancer. According to GlobalData,...
BI-3706674 by Boehringer Ingelheim International for Gastric Cancer: Likelihood of Approval
BI-3706674 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Gastric Cancer. According to GlobalData,...